Global AI in Remote Patient Monitoring (RPM) Market Size study & Forecast, by Component (Device: Wearable, Implantable, Portable; Software, Service) by Indication (Cardiac, Neuro, Onco, Diabetes, Sleep, Mental Health) and End User (Hospitals, Clinics, Pay

The Global AI in Remote Patient Monitoring (RPM) Market, valued at approximately USD 1.96 billion in 2024, is set to witness an impressive expansion at a CAGR of 27.5% from 2025 to 2035. AI-powered RPM solutions are rapidly reshaping the landscape of patient care by enabling continuous, data-driven monitoring outside traditional healthcare settings. Through sophisticated algorithms, predictive analytics, and real-time alerts, these systems facilitate early detection of complications, reduce hospital readmissions, and enhance patient engagement in disease management. This transformation is being accelerated by the surge in chronic disease prevalence, an aging population, and the healthcare sector’s shift towards value-based care models. Furthermore, advancements in wearable technology, miniaturized sensors, and interoperability standards are allowing providers to integrate vast streams of patient-generated health data seamlessly into clinical decision-making processes.

The accelerating adoption of AI-driven RPM is closely tied to the growing need for proactive, preventive healthcare delivery. With cardiovascular disorders, diabetes, neurodegenerative diseases, and oncology cases on the rise, clinicians are increasingly relying on AI models to identify risk patterns and recommend timely interventions. According to industry sources, remote monitoring adoption rates in chronic care programs have doubled over the past five years, with AI-enhanced analytics proving instrumental in improving patient outcomes while lowering operational costs. Moreover, the integration of AI with wearable and implantable devices, combined with cloud-based platforms, is enabling care providers to scale monitoring capabilities for large patient populations without compromising quality. While the market is poised for exponential growth, data privacy concerns, regulatory complexities, and infrastructure disparities in low-resource regions remain important considerations for stakeholders.

Regionally, North America held the largest share of the AI in RPM market in 2025, supported by advanced healthcare infrastructure, widespread broadband penetration, and a robust ecosystem of technology innovators. High adoption rates of telehealth, favorable reimbursement policies, and an emphasis on personalized medicine further bolster the region’s leadership. Europe continues to gain momentum with its emphasis on digital health integration and stringent healthcare quality standards. Meanwhile, the Asia Pacific region is projected to experience the fastest growth during the forecast period, fueled by rapid urbanization, rising healthcare expenditure, and government-backed digital health initiatives in countries like China, India, and Japan. The increasing prevalence of chronic conditions and the pressing need to bridge care gaps in remote areas make AI-enabled RPM an attractive investment for healthcare systems across APAC.

Major market players included in this report are:
• Philips Healthcare
• Medtronic plc
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• IBM Watson Health
• Cerner Corporation (Oracle Health)
• ResMed Inc.
• Dexcom, Inc.
• Abbott Laboratories
• Masimo Corporation
• AliveCor, Inc.
• BioTelemetry, Inc. (a Philips company)
• Omron Healthcare, Inc.
• Boston Scientific Corporation
• Biotronik SE & Co. KG

Global AI in Remote Patient Monitoring (RPM) Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Component:
• Device (Wearable, Implantable, Portable)
• Software
• Service

By Indication:
• Cardiac
• Neuro
• Onco
• Diabetes
• Sleep
• Mental Health

By End User:
• Hospitals
• Clinics
• Payer

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more